Marigot Ltd. (Cork, Ireland), which produces and markets the Aquamin line of marine-based ingredients, has developed a new blend specifically for joint health, called Aquamin Plus. This proprietary blend contains Aquamin (a red algae ingredient harvested in the fjords of Iceland high in calcium and 73 other minerals), Aquamin Mg (a magnesium ingredient produced from Irish seawater), Enzogenol and vitamin D.
 
A 2019 study and 2020 paper published in the Complementary Therapies of Medicine by Heffernan, et al, at the University College Dublin, compared Aquamin Plus to glucosamine in a double-blind crossover study on mild-symptomatic osteoarthritis patients. The results demonstrated that Aquamin Plus was superior to glucosamine in many ways. Aquamin Plus improved overall quality of life, reduced pain level, increased the distance subjects could walk, and reduced patient use of NSAIDs by 72% compared to patients on glucosamine.
 
Aquamin Plus is now commercial and is being produced and marketed by Stauber. Stauber has been in the distribution and processing of dietary supplement, food, pet and personal care ingredients since 1969 and was acquired by Hawkins Inc in 2015. Aquamin Plus is being produced in the U.S. at Stauber’s Florida, NY processing plant. Aquamin Plus is available in two forms, the first is a “ready to tablet” granular blend with excipients and the second is an excipient free powdered blend. 
 
Aquamin Plus can be produced in tablets, or used in capsules, powdered drinks, food products, and in a wide range of applications.